Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 51 of 100, showing 5 Applications out of 500 total, starting on record 251, ending on 255

# Protocol No Study Title Investigator(s) & Site(s)

251.

ECCT/20/08/01   CorNeat EverPatch
    The CorNeat EverPatch – A First-In-Human Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts       
Principal Investigator(s)
1. Lily Adhiambo Nyamai
Site(s) in Kenya
1. Lions SightFirst Hospital (Nairobi City county)
2. Kenyatta National Hospital (Nairobi City county)
3. Kwale Eye Centre (Kwale county)
 
View

252.

ECCT/20/06/04   ANTICOV (01 COV)
    An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild /moderate cases of COVID-19   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Mbagathi Infectious Disease Hospital (Nairobi City county)
2. Kenyatta University Teaching, Referral and Research Hospital (Nairobi City county)
 
View

253.

ECCT/20/07/01   Convalescent plasma trial
    A randomized control trial comparing convalescent plasma therapy plus standard treatment versus standard treatment alone in patients with severe COVID-19 pneumonia at a tertiary hospital   
Principal Investigator(s)
1. Dr Isaac Adembesa Kadambi
Site(s) in Kenya
Kenyatta University Teaching Referral and Research Hospital
 
View

254.

ECCT/20/06/03   CVIA078
    A Phase 2b randomized, open-label, controlled, single center study in Plasmodium falciparum-infected and uninfected adults age 18-55 years old in Kenya to evaluate the efficacy of the delayed, fractional dose RTS,S/AS01E malaria vaccine in subjects treated with artemisinin combination therapy plus primaquine   
Principal Investigator(s)
1. Nathanial Kelsey Copeland
Site(s) in Kenya
Kombewa Clinical Research Centre
 
View

255.

ECCT/20/06/05   SEVUSMART Trial
    SEVUSMART TRIAL   Sevuparin as a potential adjunctive therapy in children with severe malaria   
Principal Investigator(s)
1. Kathryn Maitland Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View